Elevance Health (ELV) 4: Kaye Mark sold 4,161 shares at $386.43 on 2026-10-02; Kaye… (Oct 6, 2026)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-10-02 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Elevance Health, Inc. (ELV) CIK: 0001156039 --- Reporting Owner --- Name: Kaye Mark CIK: 0001748691 Role: Officer (EVP & CFO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-10-02 | Code: F (Payment of exercise/tax) Shares: -4,161 | Price: $386.43 Total Value: $1,607,935.23 Shares Owned After: 27,876 | Ownership: D (Direct) Footnotes: [F1] PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. [Transaction #2] Security: Common Stock Date: 2026-10-02 | Code: A (Grant or award) Shares: +2,627 | Price: $0.00 Shares Owned After: 30,503 | Ownership: D (Direct) Footnotes: [F2] Represents performance based restricted share units. Restrictions lapsed on 10/2/2026. --- Footnotes (Complete Index) --- F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. F2: Represents performance based restricted share units. Restrictions lapsed on 10/2/2026. --- Signature --- /s/ /s/ Kathleen S. Kiefer, Attorney in fact (2026-10-06)